跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
洪 國盛
教授
,
傷害防治學研究所
合聘教授
,
轉譯醫學博士學位學程
合聘教授
,
臨床基因體學暨蛋白質體學碩士學位學程
主治醫師
,
臺北市立萬芳醫院
成員
,
臺北神經醫學中心
https://orcid.org/0000-0002-4147-0960
電子郵件
kshung
tmu.edu
tw
h-index
1883
引文
28
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1996 …
2024
每年研究成果
概覽
指紋
網路
專案
(12)
研究成果
(101)
類似的個人檔案
(6)
指紋
查看啟用 Kuo-Sheng Hung 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Traumatic Brain Injury
100%
Spinal Cord Injury
75%
Disease
72%
Injury
70%
Mouse
55%
Survival Rate
49%
Thioacetamide
46%
Neuroprotection
44%
Intermedin
42%
Somatomedin C
42%
Liver Fibrosis
42%
Glasgow Coma Scale
40%
Cohort Study
33%
Calpastatin
32%
Acute Liver Failure
30%
Calpain
30%
Neoplasm
29%
Sprague Dawley Rat
28%
Curcumin
28%
Injury Severity
28%
Discogenic Pain
28%
Matrix Metalloproteinase
28%
Sulfotransferase
28%
Interleukin 10
28%
Erythropoietin
26%
[1 [(1 Formyl 2 Phenylethyl)carbamoyl] 2 Methylpropyl]carbamic Acid Benzyl Ester
25%
Inflammation
25%
Cholestasis
24%
Intervertebral Disk Hernia
23%
Obstructive Jaundice
23%
Bile Acid
22%
Glutamine
22%
Dimethyl Sulfoxide
21%
Combination Therapy
21%
Endotoxin
20%
Intrathecal
20%
Bile Salt
19%
Brain Hemorrhage
18%
Glasgow Outcome Scale
17%
Hematoma
17%
Fibrinogen
17%
Transforming Growth Factor
17%
Sciatica
16%
Glioblastoma
16%
Functional Status
15%
Scoliosis
14%
Biocompatibility
14%
Disease Exacerbation
14%
Hemifacial Spasm
14%
Hypoxia
14%
Medicine and Dentistry
Bile Duct Ligation
79%
Programmed Cell Death
62%
Injury
61%
Neoplasm
59%
Hepatocyte
46%
Glioblastoma
43%
Cyberknife
42%
Stereotactic Radiosurgery
42%
Common Bile Duct
41%
Disease
32%
Gene Transfer
30%
Spinal Fusion
28%
Extracorporeal
28%
Protein P53
28%
Discogenic Pain
28%
Neurofibromatosis Type II
28%
Vestibular Schwannoma
28%
Traumatic Brain Injury
28%
Intermedin
28%
Somatomedin C
28%
Extracorporeal Shockwave Therapy
26%
Drug Therapy
25%
Bile Acid
22%
Glutamine
22%
Obstructive Jaundice
20%
Plasmid
19%
Hematoma
19%
Gene Therapy
19%
Shock (Circulatory)
17%
Ossification
16%
Intervertebral Disk Hernia
16%
Survival Rate
15%
Combination Therapy
15%
In Vitro
15%
Ganglioglioma
15%
Scoliosis
14%
Synexin
14%
Urinary Tract Infection
14%
Fibrin Scaffold
14%
Histone Deacetylase Inhibitor
14%
Cervicobrachial Neuralgia
14%
Odds Ratio
14%
Traumatic Spinal Cord Injury
14%
Brain Ventricle Peritoneum Shunt
14%
Anterior Choroidal Artery
14%
Hemifacial Spasm
14%
Injury Severity
14%
P16
14%
Transforming Growth Factor
14%
Bone Morphogenetic Protein
14%
Neuroscience
Neuroprotection
62%
Spinal Cord Injury
58%
Astrocyte
55%
Cerebral Hemorrhage
50%
Curcumin
42%
Neurotrauma
42%
Traumatic Brain Injury
42%
Erythropoietin
40%
Hematoma
37%
In Vivo
34%
In Vitro
34%
P53
28%
Cell Signaling
28%
Neurofibromatosis Type II
28%
Subdural Hematoma
28%
Acoustic Neuroma
28%
Cell Line
20%
Intrathecal
19%
Ischemia
19%
Tumor Suppressor Gene
17%
Facial Nerve
17%
Chemokine
15%
Hyperphosphorylation
15%
Synexin
14%
Monocyte Chemotactic Protein 1
14%
Glasgow Coma Scale
14%
Artificial Neural Network
14%
Adverse Effect
14%
Sulfation
14%
Radiculopathy
14%
Tumor Gene
14%
Nerve Conduction Study
14%
Refractive Error
14%
Fibrinogen
14%
Eicosanoid Receptor
14%
Methyldienolone
14%
RANTES
14%
Dextro Aspartic Acid
14%
MAPK Signaling
14%
Dopaminergic Neuron
14%
Oxidopamine
14%
Myopia
14%
Glucocorticoid
14%
Support Vector Machine
14%
Gene Transfer
14%
Cell Cycle Arrest
14%
Transforming Growth Factor
14%
Middle Cerebral Artery
14%
Proliferating Cell Nuclear Antigen
14%
Heart Rate Variability
14%
